Literature DB >> 30172017

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

David Hagin1, Yacov Shacham2, Shmuel Kivity3, Shira Benor3.   

Abstract

Entities:  

Year:  2018        PMID: 30172017     DOI: 10.1016/j.jaip.2018.07.045

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  1 in total

1.  Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Authors:  C Caruso; S Colantuono; D Pugliese; C Di Mario; B Tolusso; E Gremese; G Papparella; F Castrì; A Gasbarrini; A Romano; A Armuzzi
Journal:  Allergy Asthma Clin Immunol       Date:  2020-04-22       Impact factor: 3.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.